Description:

ODM derived from http://clinicaltrials.gov/show/NCT00195507

Link:

http://clinicaltrials.gov/show/NCT00195507

Keywords:
Versions (2) ▾
  1. 12/15/11
  2. 6/4/17
Uploaded on:

June 4, 2017

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
18 Years and older
Stable, active plaque psoriasis
Failure to respond to the following systemic therapies: Methotrexate, Cyclosporine, PUVA or Fumarate
Exclusion Criteria
Evidence of skin conditions other than psoriasis that would interfere with evaluations of the effect of the study
Systemic psoriasis therapy within 28 days prior